The multiple-antibiotic resistance regulator (MarR) plays an important role in modulating bacterial antibiotic resistance. However, the regulatory model of the marRAB operon in mycobacteria remains to be characterized. Here we report that a MarR, encoded by Ms6508, and its marRAB operon specifically contribute to rifampicin (RIF) resistance in Mycobacterium smegmatis. We show that the MarR recognizes a conserved 21-bp palindromic motif and negatively regulates the expression of two ABC transporters in the operon, encoded by Ms6509–6510. Unlike other known drug efflux pumps, overexpression of these two ABC transporters unexpectedly increased RIF sensitivity and deletion of these two genes increased mycobacterial resistance to the antibiotic....
Alternate mechanisms of drug resistance involving intrinsic defense pathways play an important role ...
Despite the availability of effective drug treatment, Mycobacterium tuberculosis (Mtb), the causativ...
2011-07-18Nontuberculosis mycobacterial infections are on a rise and are extremely difficult to trea...
InMycobacterium, multidrug efflux pumps can be associated with intrinsic drug resistance. Comparison...
Rifampin is a front-line antibiotic for the treatment of tuberculosis. Infections caused by rifampin...
Abstract Drug resistance is one of the most difficult challenges facing tuberculosis (TB) control. D...
Multidrug resistance (MDR) in bacteria has been associated with efflux pumps that export structurall...
Multidrug resistance (MDR) in bacteria has been associated with efflux pumps that export structurall...
Drug resistance is a major problem in Mycobacterium tuberculosis control, and it is critical to iden...
Drug resistance is one of the most difficult challenges facing tuberculosis (TB) control. Drug efflu...
The Mycobacterium smegmatis genome contains many genes encoding putative drug efflux pumps. Yet with...
Rifampicin is a critical first-line antibiotic for treating mycobacterial infections such as tubercu...
Multi-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux ...
The major facilitator superfamily transporter Rv1410 and the lipoprotein LprG (Rv1411) are encoded b...
Objectives: Rifampicin, a potent first-line TB drug of the rifamycin group, shows only little activi...
Alternate mechanisms of drug resistance involving intrinsic defense pathways play an important role ...
Despite the availability of effective drug treatment, Mycobacterium tuberculosis (Mtb), the causativ...
2011-07-18Nontuberculosis mycobacterial infections are on a rise and are extremely difficult to trea...
InMycobacterium, multidrug efflux pumps can be associated with intrinsic drug resistance. Comparison...
Rifampin is a front-line antibiotic for the treatment of tuberculosis. Infections caused by rifampin...
Abstract Drug resistance is one of the most difficult challenges facing tuberculosis (TB) control. D...
Multidrug resistance (MDR) in bacteria has been associated with efflux pumps that export structurall...
Multidrug resistance (MDR) in bacteria has been associated with efflux pumps that export structurall...
Drug resistance is a major problem in Mycobacterium tuberculosis control, and it is critical to iden...
Drug resistance is one of the most difficult challenges facing tuberculosis (TB) control. Drug efflu...
The Mycobacterium smegmatis genome contains many genes encoding putative drug efflux pumps. Yet with...
Rifampicin is a critical first-line antibiotic for treating mycobacterial infections such as tubercu...
Multi-drug resistant tuberculosis (MDR-TB) represents a major health problem worldwide. Drug efflux ...
The major facilitator superfamily transporter Rv1410 and the lipoprotein LprG (Rv1411) are encoded b...
Objectives: Rifampicin, a potent first-line TB drug of the rifamycin group, shows only little activi...
Alternate mechanisms of drug resistance involving intrinsic defense pathways play an important role ...
Despite the availability of effective drug treatment, Mycobacterium tuberculosis (Mtb), the causativ...
2011-07-18Nontuberculosis mycobacterial infections are on a rise and are extremely difficult to trea...